Home / Clariant Specialty Chemicals / Clariant events / AAPS PharmaSci 360
Events
Summarize
Nov 09-12, 2025 | San Antonio, TX, United States

AAPS PharmaSci 360

NORAM Health Care

Join us at the AAPS PharmSci 360 Annual Meeting, where industry leaders and innovators come together to share cutting-edge research and advancements in pharmaceutical science. This dynamic event features engaging presentations, workshops, and networking opportunities. Don’t miss the chance to connect with experts and explore the latest trends shaping the future of the industry!



Poster Presentation

Polyoxyl 35 Castor Oil, a critical solubilizer in injectable chemotherapeutics like Paclitaxel, faces challenges with color variability that can trigger regulatory concerns; our study developed and validated a scalable purification process using an optimized adsorbent blend to minimize color within regulatory limits while maintaining the excipient's functional properties and evaluating its impact on drug solubility and stability.


  • Presentation: Setting the Benchmark: Enhanced Purification of Polyoxyl 35 Castor Oil Using a Novel In-House Adsorbent System
  • Presenter: Dr. Bhushan Thekedar, Head of Global Business Development, Health Care at Clariant
  • Date: Wednesday, November 12
  • Time: 10:30 - 11:30 AM
Nov 09-12, 2025 | San Antonio, TX, United States

AAPS PharmaSci 360

NORAM Health Care
Register

Location

Henry B. Gonzalez Convention Center

Booth 2513

San Antonio, TX, United States

Ingredient highlights

  •
    VitiPure HCO
    VitiPure HCO is obtained by hydrogenation of castor oil. Hydrogenated castor oil is vegetable origin (castor oil) and is hydrophobic in nature. VitiPure HCO is in powder form intended for solid oral and topical use. At room temperature it is a fine milled solid powder with a high melting point (>80°C). In solid oral dose formulations, VitiPure HCO is applied as hydrophobic lubricant and as sustained release agent in solid oral formulations. In topical preparations, VitiPure HCO is used as viscosity enhancer and as consistency factor.
    more
  • VitiPure LEX 400
    VitiPure LEX 400 is a low molecular weight polyethylene glycol excipient type of the VitiPure LEX range for sensitive APIs and formulations. With defined microbiological and endotoxin checks of the final packed product batch, which are given individually on the certificate of analysis, we would like to support you in your individual formulation risk assessment.
    more
  • VitiPure LEX 3350 S
    VitiPure LEX 3350 is a medium molecular weight polyethylene glycol excipient type of the VitiPure LEX range for sensitive APIs and formulations. With defined microbiological & endotoxin checks of the final packed product batch, which are given individually on the certificate of analysis, we would like to support you in your individual formulation risk assessment.
    more
  • VitiPure CO 35 Superior
    VitiPure CO 35 Superior is a non-ionic solubilizer and emulsifying agent for human and veterinary pharmaceutical markets. It is manufactured by ethoxylating castor oil in a molar ratio of 1:35. VitiPure CO 35 Superior is then purified with a patented process to reduce residual impurities yielding transparent almost colorless oily liquid which forms clear solutions in water. Typically used in sensitive applications where final formulations need to be colorless, or the API is sensitive to residual impurities. And where the end formulation needs to have low microbial load with low endotoxins.
    more
  • VitiPure CO 35 LEX
    VitiPure CO 35 is a non-ionic solubiliser and emulsifying agent for the human and veterinary pharmaceutical industries. It is made by reacting castor oil with ethylene oxide in a molar ratio of 1:35. At room temperature it appears as pale-yellow oily liquid. It forms clear solutions in water. The LEX grade represents Low Endotoxins & Low bioburden grade product especially suitable for customers using it in high-risk applications.
    more
  • VitiPure CO 35
    VitiPure CO 35 is a non-ionic solubiliser and emulsifying agent for the human and veterinary pharmaceutical industries. It is made by reacting castor oil with ethylene oxide in a molar ratio of 1:35. At room temperature it appears as pale-yellow oily liquid. It forms clear solutions in water. It is typically used into formulations such as Topicals (Cream, Hot processing), Solid orals (Hot melt extrusion, Spray drying, Hard shell capsules, Soft shell capsules, Tablets, Instant release), Liquid preparations (Solution).
    more

          Page summary

          close
          Summarization in progress
          The page summary is generated by AI